Science|Business Reporting

In a show of faith in European biomedical research, the pharma company is extending its open innovation approach and setting up a bioincubator at its campus in Beerse, Belgium. Start-ups using the facility will have access to expertise, equipment and funding

The first of two joint European Space Agency–Roscosmos missions to Mars has begun a seven-month journey to the planet, where will it look for methane in the atmosphere and assess if the gas was generated by micro-organisms or is a result of geological activity

To fight growing antimicrobial resistance, the use of existing antimicrobial drugs should be restricted, and there should be incentives for new ones should be developed

Leading research bodies are asking for an urgent meeting to discuss the Scottish government’s announcement of a ban on GM cultivation. The decision has no basis in scientific fact and is anti-science in Scotland, they say

An analysis of journal papers indicates IMI’s research has a high impact, but the partnership’s former head Michel Goldman says bibliometrics do not properly reflect the interests of participants. New metrics are needed to assess interdisciplinary projects

Support mechanisms for technology transfer and collaborations are frustrating and confusing. As a result the UK is not reaping the full potential of connecting companies with university research

Summit gathered experts from academia, industry and policy to debate new energy technologies and accelerating the shift to a low-carbon economy

Better use of support mechanisms put in place by the European Medicines Agency has increased the success rate of SMEs applying for approval of new medicines

The push to share data is seldom seen through the eyes of scientists. A new study assesses opinions of five European research groups, to inform policy on how to incentivise data sharing

International R&D funding bodies should contribute to a single fund to develop new antibiotics, says an independent commission established by UK government to draw up a global plan to deal with antimicrobial resistance